These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21478428)

  • 1. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.
    Ghosh A; Murugesan G; Chen K; Zhang L; Wang Q; Febbraio M; Anselmo RM; Marchant K; Barnard J; Silverstein RL
    Blood; 2011 Jun; 117(23):6355-66. PubMed ID: 21478428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
    Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
    Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis.
    Madan N; Ghazi AR; Kong X; Chen ES; Shaw CA; Edelstein LC
    PLoS Genet; 2019 Jul; 15(7):e1008287. PubMed ID: 31344026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.
    Srikanthan S; Li W; Silverstein RL; McIntyre TM
    J Thromb Haemost; 2014 Nov; 12(11):1906-17. PubMed ID: 25163645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypochlorite-oxidized LDL induces intraplatelet ROS formation and surface exposure of CD40L--a prominent role of CD36.
    Assinger A; Koller F; Schmid W; Zellner M; Koller E; Volf I
    Atherosclerosis; 2010 Nov; 213(1):129-34. PubMed ID: 20701912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
    Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
    Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
    Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
    Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.
    Chen K; Febbraio M; Li W; Silverstein RL
    Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
    Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
    J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
    J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.
    Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.
    Kar NS; Ashraf MZ; Valiyaveettil M; Podrez EA
    J Biol Chem; 2008 Mar; 283(13):8765-71. PubMed ID: 18245080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding.
    Jay AG; Chen AN; Paz MA; Hung JP; Hamilton JA
    J Biol Chem; 2015 Feb; 290(8):4590-4603. PubMed ID: 25555908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: Diabetes affects CD36 and oxLDL uptake.
    Kanoke A; Nishijima Y; Ljungberg M; Omodaka S; Yang SY; Wong S; Rabiller G; Tominaga T; Hsieh CL; Liu J
    Exp Neurol; 2020 Dec; 334():113461. PubMed ID: 32926860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 is a receptor for oxidized low density lipoprotein.
    Endemann G; Stanton LW; Madden KS; Bryant CM; White RT; Protter AA
    J Biol Chem; 1993 Jun; 268(16):11811-6. PubMed ID: 7685021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain.
    Pearce SF; Roy P; Nicholson AC; Hajjar DP; Febbraio M; Silverstein RL
    J Biol Chem; 1998 Dec; 273(52):34875-81. PubMed ID: 9857015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.
    Love-Gregory L; Sherva R; Schappe T; Qi JS; McCrea J; Klein S; Connelly MA; Abumrad NA
    Hum Mol Genet; 2011 Jan; 20(1):193-201. PubMed ID: 20935172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse CD36 expression among Japanese population: defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects.
    Masuda Y; Tamura S; Matsuno K; Nagasawa A; Hayasaka K; Shimizu C; Moriyama T
    Thromb Res; 2015 May; 135(5):951-7. PubMed ID: 25798958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.
    Rios FJ; Koga MM; Ferracini M; Jancar S
    PLoS One; 2012; 7(5):e36632. PubMed ID: 22570732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.